Search research articles
Contact Us
Filters
Showing results (51-60 of 198) with videos related to
Page
of 20
Sort By:
Journal of Neuroendocrinology
|
August 8, 2025
Impact on symptoms and survival of bone metastases in patients with small-intestinal neuroendocrine tumours
Maria Wedin, Eva Tiensuu Janson, Göran Wallin, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
March 28, 2008
Double affinity amplification of galectin-ligand interactions through arginine-arene interactions: synthetic, thermodynamic, and computational studies with aromatic diamido thiodigalactosides
Ian Cumpstey, Emma Salomonsson, Anders Sundin, et al.
Nature Reviews. Endocrinology
|
December 11, 2013
Neuroendocrine tumours: the role of imaging for diagnosis and therapy
Martijn van Essen, Anders Sundin, Eric P Krenning, et al.
Chembiochem : a European Journal of Chemical Biology
|
July 17, 2007
Studies of arginine-arene interactions through synthesis and evaluation of a series of galectin-binding aromatic lactose esters
Ian Cumpstey, Emma Salomonsson, Anders Sundin, et al.
Journal of Neuroendocrinology
|
April 9, 2024
Prevalence of metastases outside the liver and abdominal lymph nodes on <sup>68</sup>Ga-DOTATOC-PET/CT in patients with small intestinal and pancreatic neuroendocrine tumours
Maria Wedin, Eva Tiensuu Janson, Göran Wallin, et al.
Annals of the New York Academy of Sciences
|
May 22, 2004
PET in the diagnosis of neuroendocrine tumors
Anders Sundin, Barbro Eriksson, Mats Bergström, et al.
The Journal of Organic Chemistry
|
July 29, 2006
Absence of reverse anomeric effect in furanosides
Hans Grundberg, Johan Eriksson-Bajtner, Karl-Erik Bergquist, et al.
Acta Oncologica (Stockholm, Sweden)
|
July 27, 2007
Malignant ileocaecal serotonin-producing carcinoid tumours: the presence of a solid growth pattern and/or Ki67 index above 1% identifies patients with a poorer prognosis
Janet L Cunningham, Lars Grimelius, Anders Sundin, et al.
Bioorganic & Medicinal Chemistry
|
June 12, 2010
1H-1,2,3-triazol-1-yl thiodigalactoside derivatives as high affinity galectin-3 inhibitors
Bader A Salameh, Ian Cumpstey, Anders Sundin, et al.
Clinical Nuclear Medicine
|
November 8, 2016
SPECT/CT's Advantage for Preoperative Localization of Small Parathyroid Adenomas in Primary Hyperparathyroidism
Patricia Sandqvist, Inga-Lena Nilsson, Per Grybäck, et al.
Page
of 20
Search research articles
Search
Showing results (51-60 of 198) with videos related to
Sort By:
Page
of 20
Journal of Neuroendocrinology
|
August 8, 2025
Impact on symptoms and survival of bone metastases in patients with small-intestinal neuroendocrine tumours
Maria Wedin, Eva Tiensuu Janson, Göran Wallin, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
March 28, 2008
Double affinity amplification of galectin-ligand interactions through arginine-arene interactions: synthetic, thermodynamic, and computational studies with aromatic diamido thiodigalactosides
Ian Cumpstey, Emma Salomonsson, Anders Sundin, et al.
Nature Reviews. Endocrinology
|
December 11, 2013
Neuroendocrine tumours: the role of imaging for diagnosis and therapy
Martijn van Essen, Anders Sundin, Eric P Krenning, et al.
Chembiochem : a European Journal of Chemical Biology
|
July 17, 2007
Studies of arginine-arene interactions through synthesis and evaluation of a series of galectin-binding aromatic lactose esters
Ian Cumpstey, Emma Salomonsson, Anders Sundin, et al.
Journal of Neuroendocrinology
|
April 9, 2024
Prevalence of metastases outside the liver and abdominal lymph nodes on <sup>68</sup>Ga-DOTATOC-PET/CT in patients with small intestinal and pancreatic neuroendocrine tumours
Maria Wedin, Eva Tiensuu Janson, Göran Wallin, et al.
Annals of the New York Academy of Sciences
|
May 22, 2004
PET in the diagnosis of neuroendocrine tumors
Anders Sundin, Barbro Eriksson, Mats Bergström, et al.
The Journal of Organic Chemistry
|
July 29, 2006
Absence of reverse anomeric effect in furanosides
Hans Grundberg, Johan Eriksson-Bajtner, Karl-Erik Bergquist, et al.
Acta Oncologica (Stockholm, Sweden)
|
July 27, 2007
Malignant ileocaecal serotonin-producing carcinoid tumours: the presence of a solid growth pattern and/or Ki67 index above 1% identifies patients with a poorer prognosis
Janet L Cunningham, Lars Grimelius, Anders Sundin, et al.
Bioorganic & Medicinal Chemistry
|
June 12, 2010
1H-1,2,3-triazol-1-yl thiodigalactoside derivatives as high affinity galectin-3 inhibitors
Bader A Salameh, Ian Cumpstey, Anders Sundin, et al.
Clinical Nuclear Medicine
|
November 8, 2016
SPECT/CT's Advantage for Preoperative Localization of Small Parathyroid Adenomas in Primary Hyperparathyroidism
Patricia Sandqvist, Inga-Lena Nilsson, Per Grybäck, et al.
Page
of 20